{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T14:46:47Z","timestamp":1746715607400,"version":"3.40.5"},"reference-count":22,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>Infectious meningitis (IM) in US children is increasingly rare and new rapid multiplex PCR-based testing is increasingly available. We evaluated the added value of cerebrospinal fluid (CSF) protein and glucose tests to predict IM when compared with information provided by CSF white blood cell count (WBC) and multiplex polymerase chain reaction (PCR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We retrospectively reviewed CSF results from October 2015 to August 2017 in patients 0 to 18 years at a US children\u2019s hospital. Noninfectious evaluations were excluded. Test characteristics were calculated for CSF WBC, protein, and glucose in isolation and in parallel for prediction of microbiologically confirmed IM. Chart review was performed to identify consideration of protein and glucose in medical decision-making (MDM).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>We identified 735 patients including 446 &amp;lt;2 months; 45 (6.1%) had microbiologically-confirmed IM, including 23 (5.2%) age &amp;lt;2 months. Multiplex PCR and\/or CSF WBC identified all IM patients. When added to CSF WBC, measurement of glucose made no contribution to sensitivity, specificity, positive predictive value (PPV) or negative predictive value (NPV), and protein had no impact on sensitivity and decreased the specificity, PPV, and NPV compared with CSF WBC alone. Abnormal protein was documented in MDM in 6 (0.8%) patients, all of whom had elevated WBC counts also cited. Glucose was not mentioned in MDM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Multiplex PCR testing and WBC may be sufficient to predict meningitis in children in low incidence settings. Protein and glucose did not contribute significant additional information. More intentional use of protein and glucose testing in patients with suspected IM may achieve higher value care.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2021-006435","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T08:06:12Z","timestamp":1649059572000},"page":"481-490","source":"Crossref","is-referenced-by-count":1,"title":["Reassessing the Value of CSF Protein and Glucose Measurement in Pediatric Infectious Meningitis"],"prefix":"10.1542","volume":"12","author":[{"given":"Wesley N.","family":"McLaughlin","sequence":"first","affiliation":[{"name":"aDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Lamb","sequence":"additional","affiliation":[{"name":"bColorado School of Public Health, Center for Global Health, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Gaensbauer","sequence":"additional","affiliation":[{"name":"cMayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"issue":"21","key":"2023112014385333500_b1","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial meningitis in the United States, 1998-2007","volume":"364","author":"Thigpen","year":"2011","journal-title":"N Engl J Med"},{"key":"2023112014385333500_b2","unstructured":"Centers for Disease Control and Prevention. Pneumococcal disease: surveillance and trends. Available at: https:\/\/www.cdc.gov\/pneumococcal\/surveillance.html. Accessed November 11, 2021"},{"key":"2023112014385333500_b3","unstructured":"Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report, 2019. Available at: https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2019.pdf. Accessed December 1, 2021"},{"issue":"3","key":"2023112014385333500_b4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826","article-title":"Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance","volume":"173","author":"Nanduri","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"1","key":"2023112014385333500_b5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.diagmicrobio.2016.05.020","article-title":"Potential clinical impact of the film array meningitis encephalitis panel in children with suspected central nervous system infections","volume":"86","author":"Messacar","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"2023112014385333500_b6","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/JCM.00730-16","article-title":"Multicenter evaluation of BioFire Filmarray Meningitis\/Encephalitis Panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens","volume":"54","author":"Leber","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2023112014385333500_b7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1159\/000517630","article-title":"Normal values for cerebrospinal fluid in neonates: a systematic review","volume":"118","author":"Zimmermann","year":"2021","journal-title":"Neonatology"},{"key":"2023112014385333500_b8","article-title":"A history of bacterial meningitis","volume-title":"Handbook of Clinical Neurology: History of Neurology","author":"Tyler","year":"2010"},{"key":"2023112014385333500_b9","first-page":"5","article-title":"Routine cerebrospinal fluid (CSF) analysis","volume-title":"European Handbook of Neurological Management","author":"Deisenhammer","year":"2011","edition":"2nd ed."},{"key":"2023112014385333500_b10","unstructured":"Centers for Disease Control and Prevention. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP) 2013. Available at: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6202a1.htm. Accessed June 10, 2020"},{"issue":"12","key":"2023112014385333500_b11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/INF.0b013e318180b3b9","article-title":"Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis","volume":"27","author":"Jordan","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"2023112014385333500_b12","unstructured":"Biomerieux. The BioFire FilmArray meningitis\/encephalitis (ME) panel. Available at: https:\/\/www.biofiredx.com\/products\/the-filmarray-panels\/filmarrayme\/. Accessed February 1, 2022"},{"issue":"4","key":"2023112014385333500_b13","doi-asserted-by":"crossref","first-page":"115394","DOI":"10.1016\/j.diagmicrobio.2021.115394","article-title":"Impact of the FilmArray meningitis\/encephalitis panel on antimicrobial duration among patients with suspected central nervous system infection","volume":"100","author":"Goodlet","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"2023112014385333500_b14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0897190017737697","article-title":"Cost justification of the BioFire FilmArray Meningitis\/Encephalitis Panel versus standard of care for diagnosing meningitis in a community hospital","volume":"32","author":"Soucek","year":"2019","journal-title":"J Pharm Pract"},{"issue":"1","key":"2023112014385333500_b15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s15010-018-1212-7","article-title":"Clinical benefits of introducing real-time multiplex PCR for cerebrospinal fluid as routine diagnostic at a tertiary care pediatric center","volume":"47","author":"Eichinger","year":"2019","journal-title":"Infection"},{"issue":"4","key":"2023112014385333500_b16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.diagmicrobio.2018.10.012","article-title":"Cost of managing meningitis and encephalitis among infants and children in the United States","volume":"93","author":"Balada-Llasat","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2023112014385333500_b17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2217\/fmb-2017-0238","article-title":"Economic analysis of rapid multiplex polymerase chain reaction testing for meningitis\/encephalitis in pediatric patients","volume":"13","author":"Duff","year":"2018","journal-title":"Future Microbiol"},{"issue":"4","key":"2023112014385333500_b18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1542\/peds.110.4.712","article-title":"Development and validation of a multivariable predictive model to distinguish bacterial from aseptic meningitis in children in the post-haemophilus influenzae era","volume":"110","author":"Nigrovic","year":"2002","journal-title":"Pediatrics"},{"issue":"1","key":"2023112014385333500_b19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.297.1.52","article-title":"Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis","volume":"297","author":"Nigrovic","year":"2007","journal-title":"JAMA"},{"issue":"3","key":"2023112014385333500_b20","doi-asserted-by":"crossref","first-page":"e20201126","DOI":"10.1542\/peds.2020-1126","article-title":"Clinical prediction rule for distinguishing bacterial from aseptic meningitis","volume":"146","author":"Mintegi","year":"2020","journal-title":"Pediatrics"},{"key":"2023112014385333500_b21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4613-1591-9_1","article-title":"A Brief History of the Understanding of Cerebrospinal Fluid","volume-title":"The Cerebrospinal Fluid","author":"Herndon","year":"1989","edition":"1st ed."},{"issue":"6","key":"2023112014385333500_b22","doi-asserted-by":"crossref","first-page":"e20160270","DOI":"10.1542\/peds.2016-0270","article-title":"Management and outcomes of previously healthy, full-term, febrile infants ages 7 to 90 days","volume":"138","author":"Greenhow","year":"2016","journal-title":"Pediatrics"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/5\/481\/1573267\/hpeds.2021-006435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/5\/481\/1573267\/hpeds.2021-006435.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:40:30Z","timestamp":1700491230000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/12\/5\/481\/186700\/Reassessing-the-Value-of-CSF-Protein-and-Glucose"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,4,4]]},"published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2021-006435","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"type":"print","value":"2154-1663"},{"type":"electronic","value":"2154-1671"}],"subject":[],"published":{"date-parts":[[2022,4,4]]}}}